quinoxalines has been researched along with Adverse Drug Event in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 12 (63.16) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Correia, C; Correia, T; Fernandes, S; Filipe, P; Soares-de-Almeida, L | 1 |
| Avihingsanon, A; Cheevadhanarak, S; Chirapongsathorn, S; Chuaypen, N; Jinato, T; Nookaew, I; Tanaka, Y; Tangkijvanich, P | 1 |
| Agarwal, K; Aguilar, H; Asselah, T; Calinas, F; Colombo, M; de Ledinghen, V; Elkhashab, M; Hassanein, T; Hezode, C; Horsmans, Y; Kort, J; Kowdley, KV; Krishnan, P; Lin, CW; Liu, R; Mantry, PS; Marinho, RT; Mensa, FJ; Nevens, F; Ng, TI; Wang, S; Zadeikis, N | 1 |
| Badshah, C; Barr, E; Brown, A; Durkan, C; Foster, GR; Haber, B; Hézode, C; Lahser, F; Roberts, SK; Robertson, M; Wahl, J; Zekry, A; Zhang, B; Zuckerman, E | 1 |
| Béguelin, C; Bernasconi, E; Böni, J; Braun, DL; Conen, A; Delaloye, J; Fehr, JS; Flepp, M; Günthard, HF; Hampel, B; Kouyos, R; Künzler-Heule, P; Nguyen, H; Nicca, D; Rauch, A; Rougemont, M; Schmid, P; Shah, C; Stöckle, M | 1 |
| Burki, TK | 1 |
| Buggy, Y; Cornelius, V; Fogg, C; Kasliwal, R; Layton, D; Shakir, SA | 1 |
| Härmark, L; Oosterhuis, I; van Puijenbroek, E | 1 |
| An, D; Brainard, DM; Di Bisceglie, AM; Dvory-Sobol, H; Freilich, B; Glass, S; Hassman, D; Hill, J; Kim, S; Kirby, BJ; Krefetz, D; Lawitz, E; Marbury, T; Rodriguez-Torres, M; Smith, W; Stamm, LM; Taylor, JG; Yang, JC | 1 |
| Baruch, Y; Ben Ari, Z; Bhanja, S; Bruck, R; Gane, E; Howe, AY; Hwang, P; Mollison, L; Robertson, MN; Wahl, J; Zhao, Y; Zuckerman, E | 1 |
| Castell, C; Jiang, J; Lager, J; Liu, L; Mutch, D; Traynor, AM; Wheler, J | 1 |
| Kranzler, HR; Oncken, CA | 1 |
| Ockene, I; Salmoirago-Blotcher, E | 1 |
| Arteaga, C; Benowitz, NL; Garza, D; Pipe, AL; Rigotti, NA; Tonstad, S | 1 |
| Anthenelli, RM; George, TP; Morris, CD; Thompson, JR; Treadow, J; Williams, JM; Yunis, C | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Gobey, JS; Smith, BJ | 1 |
| Gilbert, M; Laustsen, G; Wimett, L | 1 |
| Billing, CB; Gong, J; Pennington, AM; Reeves, KR; Spangler, JG; Williams, KE | 1 |
| Welch, SL | 1 |
3 review(s) available for quinoxalines and Adverse Drug Event
| Article | Year |
|---|---|
Varenicline-induced drug eruption: case and review of the literature.
Topics: Acute Generalized Exanthematous Pustulosis; Benzazepines; Drug-Related Side Effects and Adverse Reactions; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2023 |
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
Topics: Animals; Benzazepines; Bupropion; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Nicotine; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2009 |
Oral toxicity of topical preparations.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anesthetics, Local; Animals; Anti-Bacterial Agents; Benzoyl Peroxide; Brimonidine Tartrate; Calcitriol; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Imidazoles; Ointments; Quinoxalines; Salicylates; Vitamin A; Vitamin D; Zinc Oxide | 2002 |
9 trial(s) available for quinoxalines and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.
Topics: Adult; Aged; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Placebos; Proline; Pyrrolidines; Quinoxalines; Sulfonamides; Treatment Outcome | 2018 |
Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amides; Antiviral Agents; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Quinoxalines; Ribavirin; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Young Adult | 2018 |
Erdafitinib for advanced urothelial carcinoma.
Topics: Carcinoma, Transitional Cell; Drug-Related Side Effects and Adverse Reactions; Humans; Mutation; Progression-Free Survival; Protein Kinase Inhibitors; Pyrazoles; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3; Urologic Neoplasms; Urothelium | 2019 |
GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study.
Topics: Adolescent; Adult; Aged; Aminoisobutyric Acids; Antiviral Agents; Cyclopropanes; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Macrocyclic Compounds; Male; Middle Aged; Placebos; Proline; Quinoxalines; Sulfonamides; Treatment Outcome; Viral Load; Young Adult | 2016 |
Efficacy and safety of grazoprevir + ribavirin for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1 infection.
Topics: Adult; Amides; Antiviral Agents; Carbamates; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Quinoxalines; Recurrence; Ribavirin; Sulfonamides; Sustained Virologic Response; Treatment Outcome | 2016 |
Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinoxalines; Sulfonamides | 2017 |
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
Topics: Aged; Benzazepines; Cardiovascular Diseases; Directive Counseling; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking Cessation; Survival Rate; Treatment Outcome; Varenicline | 2010 |
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Aged; Benzazepines; Canada; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking Cessation; United States; Varenicline | 2012 |
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.
Topics: Administration, Oral; Adolescent; Adult; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Health; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Varenicline | 2006 |
7 other study(ies) available for quinoxalines and Adverse Drug Event
| Article | Year |
|---|---|
Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.
Topics: Adult; Aged; Antiviral Agents; Benzofurans; Coinfection; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dysbiosis; Female; Gastrointestinal Microbiome; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Quinoxalines; Treatment Outcome; Viral Load | 2021 |
High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.
Topics: Adult; Aged; Amides; Antiviral Agents; Benzofurans; Carbamates; Cyclopropanes; Drug Resistance, Viral; Drug-Related Side Effects and Adverse Reactions; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Imidazoles; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Quinoxalines; Ribavirin; Sulfonamides; Sustained Virologic Response; Treatment Outcome | 2019 |
Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in England.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Benzazepines; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; England; Female; General Practice; Humans; Incidence; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Smoking Cessation; Varenicline | 2013 |
Experiences with the use of varenicline in daily practice in the Netherlands: a prospective, observational cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Netherlands; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult | 2014 |
Varenicline for smoking cessation in patients with coronary heart disease.
Topics: Benzazepines; Cardiovascular Diseases; Coronary Disease; Drug-Related Side Effects and Adverse Reactions; Humans; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
Drug approvals.
Topics: Acetanilides; Alprostadil; Angina Pectoris; Benzazepines; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Fatty Acids; Herpes Zoster Vaccine; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Ibandronic Acid; Insulin; Lubiprostone; Naltrexone; Narcotic Antagonists; Nurse's Role; Papillomavirus Vaccines; Patient Education as Topic; Piperazines; Quinoxalines; Ranolazine; Triazoles; United States; United States Food and Drug Administration; Varenicline | 2007 |
Comment and reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
Topics: Benzazepines; Drug-Related Side Effects and Adverse Reactions; Humans; Quinoxalines; Smoking Cessation; Time Factors; Varenicline | 2008 |